151 related articles for article (PubMed ID: 37736951)
21. Vaping associated lung injury: A potentially life-threatening epidemic in US youth.
Messina MD; Levin TL; Conrad LA; Bidiwala A
Pediatr Pulmonol; 2020 Jul; 55(7):1705-1711. PubMed ID: 32251551
[TBL] [Abstract][Full Text] [Related]
22. CT Findings and Patterns of e-Cigarette or Vaping Product Use-Associated Lung Injury: A Multicenter Cohort of 160 Cases.
Kligerman SJ; Kay FU; Raptis CA; Henry TS; Sechrist JW; Walker CM; Vargas D; Filev PD; Chung MS; Digumarthy SR; Ropp AM; Mohammed TL; Pope KW; Marquis KM; Chung JH; Kanne JP
Chest; 2021 Oct; 160(4):1492-1511. PubMed ID: 33957099
[TBL] [Abstract][Full Text] [Related]
23. Vaping-Associated Lung Injury: A New Cause of Acute Respiratory Failure.
Fedt A; Bhattarai S; Oelstrom MJ
J Adolesc Health; 2020 Jun; 66(6):754-757. PubMed ID: 32473722
[TBL] [Abstract][Full Text] [Related]
24. Characterizing e-cigarette vaping-associated lung injury in the pediatric intensive care unit.
Reddy A; Jenssen BP; Chidambaram A; Yehya N; Lindell RB
Pediatr Pulmonol; 2021 Jan; 56(1):162-170. PubMed ID: 32970368
[TBL] [Abstract][Full Text] [Related]
25. Vaping and diffuse alveolar hemorrhage: All EVALI is not created equal.
Hoekstra NE; Dannull KA; Weinman JP; Liptzin DR; Hinds DM
Pediatr Pulmonol; 2021 Dec; 56(12):4057-4059. PubMed ID: 34551216
[TBL] [Abstract][Full Text] [Related]
26. Acute Eosinophilic Pneumonia. Causes, Diagnosis, and Management.
De Giacomi F; Vassallo R; Yi ES; Ryu JH
Am J Respir Crit Care Med; 2018 Mar; 197(6):728-736. PubMed ID: 29206477
[TBL] [Abstract][Full Text] [Related]
27. A 20-Year-Old Man with e-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Thrombotic Coagulopathy.
Harada HA; Liu J; Shortell JD; Beesley SJ
Am J Case Rep; 2021 Apr; 22():e929915. PubMed ID: 33854029
[TBL] [Abstract][Full Text] [Related]
28. Acute Eosinophilic Pneumonia Secondary to Menthol Cigarette Use: A Rare Phenomenon With a Review of Literature.
Harne PS; Rao S; Malik M; Shepherd Z
J Investig Med High Impact Case Rep; 2020; 8():2324709620925978. PubMed ID: 32462944
[TBL] [Abstract][Full Text] [Related]
29. Case of e-cigarette or vaping product use-associated lung injury (EVALI) in London, UK.
Evans RE; Herbert S; Owen W; Rao D
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33837028
[TBL] [Abstract][Full Text] [Related]
30. Acute eosinophilic pneumonia caused by nicotine-free vaping in an adolescent patient: A case report.
Takigawa Y; Sato K; Inoue A; Nagae M; Inoue T; Onishi K; Mitsumune S; Watanabe H; Kudo K; Sato A; Fujiwara K; Shibayama T
Respirol Case Rep; 2022 Jun; 10(6):e0961. PubMed ID: 35592268
[TBL] [Abstract][Full Text] [Related]
31. A 43-Year-Old Brazilian Man with Acute Impairment of Lung Function and Pulmonary Nodules with Features of Electronic Cigarette or Vaping Product Use-Associated Lung Injury (EVALI).
Lucas LGCS; Acha LFM; Lucas VS; Capone D
Am J Case Rep; 2023 May; 24():e939365. PubMed ID: 37131305
[TBL] [Abstract][Full Text] [Related]
32. Radiologic and Pathologic Correlation in EVALI.
Panse PM; Feller FF; Butt YM; Smith ML; Larsen BT; Tazelaar HD; Harvin HJ; Gotway MB
AJR Am J Roentgenol; 2020 Nov; 215(5):1057-1064. PubMed ID: 32877245
[No Abstract] [Full Text] [Related]
33. E-cigarette or vaping product use-associated lung injury: What is the role of cytologic assessment?
Saqi A; Mukhopadhyay S; Butt Y; Doxtader E; Heymann JJ; Larsen BT; Moreira AL; Patel A; Reynolds JP; Sung S; Crapanzano JP
Cancer Cytopathol; 2020 Jun; 128(6):371-380. PubMed ID: 31985892
[No Abstract] [Full Text] [Related]
34. Acute Eosinophilic Pneumonia: Correlation of Clinical Characteristics With Underlying Cause.
De Giacomi F; Decker PA; Vassallo R; Ryu JH
Chest; 2017 Aug; 152(2):379-385. PubMed ID: 28286263
[TBL] [Abstract][Full Text] [Related]
35. Improvement in Pulmonary Function Following Discontinuation of Vaping or E-Cigarette Use in Adolescents with EVALI.
Lee SA; Sayad E; Yenduri NJS; Wang KY; Guillerman RP; Farber HJ
Pediatr Allergy Immunol Pulmonol; 2021 Mar; 34(1):23-29. PubMed ID: 33734875
[No Abstract] [Full Text] [Related]
36. EVALI - E-Cigarette or Vaping Product Use-Associated Lung Injury: A Case Report.
Adhikari R; Koritala T; Gotur R; Malayala SV; Jain NK
Cureus; 2021 Feb; 13(2):e13541. PubMed ID: 33815967
[TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
38. E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) with Acute Respiratory Failure in Three Adolescent Patients: a Clinical Timeline, Treatment, and Product Analysis.
Billa R; Tigges C; Vijayakumar N; Radke J; Pedati C; Weiner R; McCabe D
J Med Toxicol; 2020 Jul; 16(3):248-254. PubMed ID: 32193828
[TBL] [Abstract][Full Text] [Related]
39. E-cigarette, or vaping, product use-associated lung injury (EVALI) treated with veno-venous extracorporeal membrane oxygenation (VV-ECMO) and ultra-protective ventilator settings.
Odish MF; Bellinghausen A; Golts E; Owens RL
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32616535
[TBL] [Abstract][Full Text] [Related]
40. Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents.
Carroll BJ; Kim M; Hemyari A; Thakrar P; Kump TE; Wade T; De Vela G; Hall J; Diaz CD; D'Andrea LA
Pediatr Pulmonol; 2020 Jul; 55(7):1712-1718. PubMed ID: 32320538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
